1 Market Overview of Elvitegravir Combination Drugs 1.1 Elvitegravir Combination Drugs Market Overview 1.1.1 Elvitegravir Combination Drugs Product Scope 1.1.2 Elvitegravir Combination Drugs Market Status and Outlook 1.2 Global Elvitegravir Combination Drugs Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Elvitegravir Combination Drugs Market Size by Region (2016-2027) 1.4 Global Elvitegravir Combination Drugs Historic Market Size by Region (2016-2021) 1.5 Global Elvitegravir Combination Drugs Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Elvitegravir Combination Drugs Market Size (2016-2027) 1.6.1 North America Elvitegravir Combination Drugs Market Size (2016-2027) 1.6.2 Europe Elvitegravir Combination Drugs Market Size (2016-2027) 1.6.3 Asia-Pacific Elvitegravir Combination Drugs Market Size (2016-2027) 1.6.4 Latin America Elvitegravir Combination Drugs Market Size (2016-2027) 1.6.5 Middle East & Africa Elvitegravir Combination Drugs Market Size (2016-2027) 2 Elvitegravir Combination Drugs Market Overview by Type 2.1 Global Elvitegravir Combination Drugs Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Elvitegravir Combination Drugs Historic Market Size by Type (2016-2021) 2.3 Global Elvitegravir Combination Drugs Forecasted Market Size by Type (2022-2027) 2.4 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug 2.5 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug 3 Elvitegravir Combination Drugs Market Overview by Application 3.1 Global Elvitegravir Combination Drugs Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Elvitegravir Combination Drugs Historic Market Size by Application (2016-2021) 3.3 Global Elvitegravir Combination Drugs Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Clinic 3.6 Drug Center 3.7 Other 4 Elvitegravir Combination Drugs Competition Analysis by Players 4.1 Global Elvitegravir Combination Drugs Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Elvitegravir Combination Drugs as of 2020) 4.3 Date of Key Players Enter into Elvitegravir Combination Drugs Market 4.4 Global Top Players Elvitegravir Combination Drugs Headquarters and Area Served 4.5 Key Players Elvitegravir Combination Drugs Product Solution and Service 4.6 Competitive Status 4.6.1 Elvitegravir Combination Drugs Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Gilead Sciences 5.1.1 Gilead Sciences Profile 5.1.2 Gilead Sciences Main Business 5.1.3 Gilead Sciences Elvitegravir Combination Drugs Products, Services and Solutions 5.1.4 Gilead Sciences Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.1.5 Gilead Sciences Recent Developments 5.2 Bristol-Myers Squibb 5.2.1 Bristol-Myers Squibb Profile 5.2.2 Bristol-Myers Squibb Main Business 5.2.3 Bristol-Myers Squibb Elvitegravir Combination Drugs Products, Services and Solutions 5.2.4 Bristol-Myers Squibb Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.2.5 Bristol-Myers Squibb Recent Developments 5.3 Janssen Pharmaceutica (Johnson & Johnson) 5.5.1 Janssen Pharmaceutica (Johnson & Johnson) Profile 5.3.2 Janssen Pharmaceutica (Johnson & Johnson) Main Business 5.3.3 Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Products, Services and Solutions 5.3.4 Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.3.5 Biocon Limited Recent Developments 5.4 Biocon Limited 5.4.1 Biocon Limited Profile 5.4.2 Biocon Limited Main Business 5.4.3 Biocon Limited Elvitegravir Combination Drugs Products, Services and Solutions 5.4.4 Biocon Limited Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.4.5 Biocon Limited Recent Developments 5.5 Flamingo Pharmaceuticals Limited 5.5.1 Flamingo Pharmaceuticals Limited Profile 5.5.2 Flamingo Pharmaceuticals Limited Main Business 5.5.3 Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Products, Services and Solutions 5.5.4 Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.5.5 Flamingo Pharmaceuticals Limited Recent Developments 5.6 IPCA Laboratories 5.6.1 IPCA Laboratories Profile 5.6.2 IPCA Laboratories Main Business 5.6.3 IPCA Laboratories Elvitegravir Combination Drugs Products, Services and Solutions 5.6.4 IPCA Laboratories Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.6.5 IPCA Laboratories Recent Developments 5.7 Medisist Pharma 5.7.1 Medisist Pharma Profile 5.7.2 Medisist Pharma Main Business 5.7.3 Medisist Pharma Elvitegravir Combination Drugs Products, Services and Solutions 5.7.4 Medisist Pharma Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.7.5 Medisist Pharma Recent Developments 5.8 Affine Formulations Limited 5.8.1 Affine Formulations Limited Profile 5.8.2 Affine Formulations Limited Main Business 5.8.3 Affine Formulations Limited Elvitegravir Combination Drugs Products, Services and Solutions 5.8.4 Affine Formulations Limited Elvitegravir Combination Drugs Revenue (US$ Million) & (2016-2021) 5.8.5 Affine Formulations Limited Recent Developments 6 North America 6.1 North America Elvitegravir Combination Drugs Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Elvitegravir Combination Drugs Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Elvitegravir Combination Drugs Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Elvitegravir Combination Drugs Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Elvitegravir Combination Drugs Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Elvitegravir Combination Drugs Market Dynamics 11.1 Elvitegravir Combination Drugs Industry Trends 11.2 Elvitegravir Combination Drugs Market Drivers 11.3 Elvitegravir Combination Drugs Market Challenges 11.4 Elvitegravir Combination Drugs Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Elvitegravir Combination Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Elvitegravir Combination Drugs Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Elvitegravir Combination Drugs Market Size Share by Region (2016-2021) Table 4. Global Elvitegravir Combination Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Elvitegravir Combination Drugs Forecasted Market Size Share by Region (2022-2027) Table 6. Global Elvitegravir Combination Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Elvitegravir Combination Drugs Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Elvitegravir Combination Drugs Revenue Market Share by Type (2016-2021) Table 9. Global Elvitegravir Combination Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Elvitegravir Combination Drugs Revenue Market Share by Type (2022-2027) Table 11. Global Elvitegravir Combination Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Elvitegravir Combination Drugs Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Elvitegravir Combination Drugs Revenue Market Share by Application (2016-2021) Table 14. Global Elvitegravir Combination Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Elvitegravir Combination Drugs Revenue Market Share by Application (2022-2027) Table 16. Global Elvitegravir Combination Drugs Revenue (US$ Million) by Players (2016-2021) Table 17. Global Elvitegravir Combination Drugs Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Elvitegravir Combination Drugs as of 2020) Table 19. Date of Key Manufacturers Enter into Elvitegravir Combination Drugs Market Table 20. Global Elvitegravir Combination Drugs Top Players Headquarters and Area Served Table 21. Elvitegravir Combination Drugs Product Solution and Service Table 22. Global Elvitegravir Combination Drugs Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Gilead Sciences Basic Information List Table 25. Gilead Sciences Description and Business Overview Table 26. Gilead Sciences Elvitegravir Combination Drugs Products, Services and Solutions Table 27. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Gilead Sciences (2016-2021) Table 28. Gilead Sciences Recent Developments Table 29. Bristol-Myers Squibb Basic Information List Table 30. Bristol-Myers Squibb Description and Business Overview Table 31. Bristol-Myers Squibb Elvitegravir Combination Drugs Products, Services and Solutions Table 32. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Bristol-Myers Squibb (2016-2021) Table 33. Bristol-Myers Squibb Recent Developments Table 34. Janssen Pharmaceutica (Johnson & Johnson) Basic Information List Table 35. Janssen Pharmaceutica (Johnson & Johnson) Description and Business Overview Table 36. Janssen Pharmaceutica (Johnson & Johnson) Elvitegravir Combination Drugs Products, Services and Solutions Table 37. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Janssen Pharmaceutica (Johnson & Johnson) (2016-2021) Table 38. Janssen Pharmaceutica (Johnson & Johnson) Recent Developments Table 39. Biocon Limited Basic Information List Table 40. Biocon Limited Description and Business Overview Table 41. Biocon Limited Elvitegravir Combination Drugs Products, Services and Solutions Table 42. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Biocon Limited (2016-2021) Table 43. Biocon Limited Recent Developments Table 44. Flamingo Pharmaceuticals Limited Basic Information List Table 45. Flamingo Pharmaceuticals Limited Description and Business Overview Table 46. Flamingo Pharmaceuticals Limited Elvitegravir Combination Drugs Products, Services and Solutions Table 47. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Flamingo Pharmaceuticals Limited (2016-2021) Table 48. Flamingo Pharmaceuticals Limited Recent Developments Table 49. IPCA Laboratories Basic Information List Table 50. IPCA Laboratories Description and Business Overview Table 51. IPCA Laboratories Elvitegravir Combination Drugs Products, Services and Solutions Table 52. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of IPCA Laboratories (2016-2021) Table 53. IPCA Laboratories Recent Developments Table 54. Medisist Pharma Basic Information List Table 55. Medisist Pharma Description and Business Overview Table 56. Medisist Pharma Elvitegravir Combination Drugs Products, Services and Solutions Table 57. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Medisist Pharma (2016-2021) Table 58. Medisist Pharma Recent Developments Table 59. Affine Formulations Limited Basic Information List Table 60. Affine Formulations Limited Description and Business Overview Table 61. Affine Formulations Limited Elvitegravir Combination Drugs Products, Services and Solutions Table 62. Revenue (US$ Million) in Elvitegravir Combination Drugs Business of Affine Formulations Limited (2016-2021) Table 63. Affine Formulations Limited Recent Developments Table 64. North America Elvitegravir Combination Drugs Market Size by Country (2016-2021) & (US$ Million) Table 65. North America Elvitegravir Combination Drugs Market Size by Country (2022-2027) & (US$ Million) Table 66. Europe Elvitegravir Combination Drugs Market Size by Country (2016-2021) & (US$ Million) Table 67. Europe Elvitegravir Combination Drugs Market Size by Country (2022-2027) & (US$ Million) Table 68. Asia-Pacific Elvitegravir Combination Drugs Market Size by Region (2016-2021) & (US$ Million) Table 69. Asia-Pacific Elvitegravir Combination Drugs Market Size by Region (2022-2027) & (US$ Million) Table 70. Asia-Pacific Elvitegravir Combination Drugs Market Share by Region (2016-2021) Table 71. Asia-Pacific Elvitegravir Combination Drugs Market Share by Region (2022-2027) Table 72. Latin America Elvitegravir Combination Drugs Market Size by Country (2016-2021) & (US$ Million) Table 73. Latin America Elvitegravir Combination Drugs Market Size by Country (2022-2027) & (US$ Million) Table 74. Middle East & Africa Elvitegravir Combination Drugs Market Size by Players (2016-2021) & (US$ Million) Table 75. Middle East & Africa Elvitegravir Combination Drugs Market Size by Country (2022-2027) & (US$ Million) Table 76. Elvitegravir Combination Drugs Market Trends Table 77. Elvitegravir Combination Drugs Market Drivers Table 78. Elvitegravir Combination Drugs Market Challenges Table 79. Elvitegravir Combination Drugs Market Restraints Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global Elvitegravir Combination Drugs Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Elvitegravir Combination Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Elvitegravir Combination Drugs Market Share by Regions: 2021 VS 2027 Figure 4. Global Elvitegravir Combination Drugs Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Elvitegravir Combination Drugs Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Elvitegravir Combination Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Elvitegravir Combination Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Elvitegravir Combination Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Elvitegravir Combination Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Elvitegravir Combination Drugs Market Size Share by Type in 2021 & 2027 Figure 11. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Combination Drug Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Combination Drug Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Elvitegravir Combination Drugs Market Size Share by Application in 2021 & 2027 Figure 14. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Drug Center Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Elvitegravir Combination Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Elvitegravir Combination Drugs Market Share in 2020 Figure 20. North America Elvitegravir Combination Drugs Market Share by Country (2016-2027) Figure 21. United States Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 22. Canada Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 23. Germany Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 24. France Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 26. Italy Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 27. Russia Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Elvitegravir Combination Drugs Market Share by Region (2016-2027) Figure 31. China Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 32. Japan Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 35. India Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 36. Australia Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Elvitegravir Combination Drugs Market Share by Country (2016-2027) Figure 39. Mexico Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Elvitegravir Combination Drugs Market Share by Country (2016-2027) Figure 43. Turkey Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 45. UAE Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Elvitegravir Combination Drugs Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Gilead Sciences Bristol-Myers Squibb Janssen Pharmaceutica (Johnson & Johnson) Biocon Limited Flamingo Pharmaceuticals Limited IPCA Laboratories Medisist Pharma Affine Formulations Limited